Who we are
Synergus RWE develop and execute Market Access and RWE strategies for Western Europe.
Evidence for decisions
Synergus RWE supports in the development and execution of European evidence strategies.
Evidence For DecisionsThe foundation for our services is to support our clients in developing evidence that will be used for decision-making. We are at the forefront of understanding how Real-World Evidence can be used to support decision-makers. |
Data that makes the differenceCombining our extensive experience using RWD with our proprietary database with more than 400 data sets, we help you find the data that will make a difference. |
RWE analysisWe can help you develop real-world evidence studies for various purposes using the best data sets and methodological approaches. |
|
|
|
Securing market access
Synergus RWE supports in the development and execution of European market access strategies.
Medical DeviceWe can support you through the different pathways for medical devices in Europe, whether it is through changing DRG systems, applying for inclusion on the implant / medical aids list , or using indirect pathways. |
PharmaWe can support you in the Nordics and through the IGES group in Europe. |
DiagnosticsDiagnostic solutions are quite different from a market access perspective since most countries do not have any formal pathway to establish reimbursement. We can help you navigate this maze to find the right solution. |
Digital HealthMarket Access in Digital Health is an evolving field in Europe. We can support you from strategy to application of reimbursement. |
Blog
News
09
Oct 2023
Synergus RWE has contributed to this important study to demonstrate the value of FreeStyle Libre, utilising the rich data from Swedish diabetes registry linked with several other data-sources.
Get in Contact